PHILADELPHIA and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutic...
BriaCell Therapeutics (BCT.TO), down 2.25% on last look, having been even lower today, on Tuesday sa...
Bria-OTS has cleared its safety evaluation in the Phase 1/2 study monotherapy dosage settingPhase 1/...
Phase 2 survival and clinical benefit data meet or exceed outcomes of FDA-approved therapies in comp...
PHILADELPHIA and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics...